However, combined IGF1R and PI3Kγ inhibition did not effectively block growth of PTEN-negative T-ALL cells, suggesting the presence of additional mechanisms driving T-ALL progression82. The gene discussed is IGF1R; the disease is acute lymphoblastic leukemia.